Smith W Bradford 4
4 · Homology Medicines, Inc. · Filed Jan 4, 2023
Insider Transaction Report
Form 4
Smith W Bradford
CFO, Treasurer & Secretary
Transactions
- Exercise/Conversion
Common Stock
2023-01-01+6,600→ 11,018 total - Exercise/Conversion
Common Stock
2023-01-01+6,930→ 17,948 total - Exercise/Conversion
Restricted Stock Units
2023-01-01−6,600→ 6,800 total→ Common Stock (6,600 underlying) - Exercise/Conversion
Restricted Stock Units
2023-01-01−6,930→ 14,070 total→ Common Stock (6,930 underlying)
Footnotes (3)
- [F1]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer common stock.
- [F2]The RSUs have vested and settled or will vest and settle, as applicable, as to approximately one third of the RSUs on each of the first three anniversaries of January 1, 2021 so that such RSUs will become fully vested on January 1, 2024. The RSUs do not have an expiration date.
- [F3]The RSUs have vested and settled or will vest and settle, as applicable, as to approximately one third of the RSUs on each of the first three anniversaries of January 1, 2022 so that such RSUs will become fully vested on January 1, 2025. The RSUs do not have an expiration date.